AbbVie Inc. (ABBV) closed fiscal year 2025 with a gross margin of 70.2 % and a net margin of 6.9 %.
AbbVie Inc. (ABBV) closed fiscal year 2025 with a gross margin of 70.2 % and a net margin of 6.9 %. The same year shows an EBITDA margin of 38.0 % and an EBIT margin of 24.6 %. The free cash flow margin was 29.1 %. Against the previous year the gross margin moved +0.2 pp and the net margin −0.7 pp. Across the period the gross margin ranges between 62.4 % in 2023 and 80.3 % in 2015. The series covers 15 fiscal years, from 2011 to 2025. Margins are expressed as a percentage of net revenue and are derived from the same figures as the income statement, taken from as-reported SEC EDGAR filings, with no restatements or adjustments of our own.
Fiscal year end: December
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin (%) | 73.41 % | 75.47 % | 75.62 % | 77.83 % | 80.31 % | 77.25 % | 75.04 % | 76.44 % | 77.64 % | 66.41 % | 68.96 % | 70.00 % | 62.42 % | 69.99 % | 70.24 % |
| EBITDA margin (%) | 28.04 % | 37.91 % | 34.92 % | 21.03 % | 36.63 % | 41.07 % | 39.15 % | 24.88 % | 45.09 % | 38.94 % | 47.06 % | 45.79 % | 39.50 % | 31.11 % | 37.96 % |
| EBIT margin (%) | 20.75 % | 31.65 % | 30.14 % | 17.09 % | 32.97 % | 36.43 % | 33.83 % | 19.49 % | 39.03 % | 24.81 % | 31.89 % | 31.21 % | 23.49 % | 16.22 % | 24.65 % |
| Net margin (%) | 19.68 % | 28.70 % | 21.97 % | 8.89 % | 22.50 % | 23.22 % | 18.82 % | 17.36 % | 23.69 % | 10.08 % | 20.54 % | 20.39 % | 8.95 % | 7.59 % | 6.91 % |
| FCF margin (%) | 33.77 % | 32.71 % | 30.74 % | 14.71 % | 30.64 % | 25.59 % | 33.42 % | 39.05 % | 38.39 % | 36.66 % | 39.13 % | 41.77 % | 40.62 % | 31.65 % | 29.13 % |
